Results 271 to 280 of about 413,694 (387)

Prediction Model for Familial Aggregated HBV‐Associated Hepatocellular Carcinoma Based on Serum Biomarkers

open access: yesCancer Reports, Volume 8, Issue 6, June 2025.
ABSTRACT Background Accurate assessment of the risk of familial aggregated hepatitis B virus (HBV)‐associated hepatocellular carcinoma (HCC) and regular surveillance for these patients at high risk may be valuable to reduce the occurrence and improve the prognosis of HCC.
Linmei Zhong   +5 more
wiley   +1 more source

Prevalence, Molecular Characterization, and Immune Status Response of Hepatitis B Virus Among Healthcare Workers in Yaoundé General Hospital, Cameroon, During May to June 2024: A Hospital‐Based Cross‐Sectional Study

open access: yesHealth Science Reports, Volume 8, Issue 6, June 2025.
ABSTRACT Background Hepatitis B virus (HBV) infection is preventable through vaccination. However, healthcare workers (HCWs) are at increased risk of HBV transmission due to occupational exposure. Aims This study investigates the prevalence of HBV markers of exposure and infection, HBV genotypes, and immunity among HCWs at Yaoundé General Hospital ...
Marie Atsama‐Amougou   +5 more
wiley   +1 more source

Rapid immunization effects of a new type of 60 μg hepatitis B vaccine compared with traditional 20 μg hepatitis B vaccines in adults. [PDF]

open access: yesHum Vaccin Immunother, 2016
Wang H   +15 more
europepmc   +1 more source

Pregnancy after cancer: FIGO Best practice advice

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 169, Issue 3, Page 1119-1126, June 2025.
Abstract Advances in cancer care have led to a growing number of cancer survivors globally. As cancer increasingly affects women and people of reproductive age, more individuals will be experiencing pregnancy after completing cancer treatment. This Best Practice Advice manuscript describes the epidemiology of pregnancy after cancer, recommended ...
Cynthia Maxwell   +23 more
wiley   +1 more source

Evaluating the Potential Adverse Effects of Favipiravir on Biochemical, Histopathological, and Spermatological Parameters in Male Rats' Testicular Tissue

open access: yesJournal of Biochemical and Molecular Toxicology, Volume 39, Issue 6, June 2025.
ABSTRACT Favipiravir is a selective RNA polymerase inhibitor and a broad‐spectrum antiviral drug. Favipiravir reduces cell proliferation by inhibiting RNA transcription, particularly in rapidly proliferating cells such as spermatogonia. The aim of this study was to investigate the effects and mechanism of action of favipiravir (T‐705) on sperm quality ...
Ali Doğan Ömür   +6 more
wiley   +1 more source

Efficacy and Durability of Immune Response After Receipt of Hepatitis A Vaccine in People With Human Immunodeficiency Virus. [PDF]

open access: yesOpen Forum Infect Dis
Kazzi B   +7 more
europepmc   +1 more source

Advances in the Role of Antimicrobial Peptides in the Management of Sexually Transmitted Infections

open access: yesJournal of Clinical Laboratory Analysis, Volume 39, Issue 11, June 2025.
The article reviews recent advancements in the use of antimicrobial peptides (AMPs) for the treatment and prevention of sexually transmitted infections (STIs), with a particular focus on research progress in combating infections such as gonorrhea, HIV, HSV, and Chlamydia, as well as the challenges and future directions in this field.
Shuangwen Xiao   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy